Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ACT001 |
Synonyms | |
Therapy Description |
ACT001 binds to SERPINE1 (PAI-1) and inhibits PI3K/AKT pathway signaling, potentially leading to inhibition of tumor cell proliferation and migration and decreased tumor growth (PMID: 31591377). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ACT001 | ACT-001|ACT 001 | ACT001 binds to SERPINE1 (PAI-1) and inhibits PI3K/AKT pathway signaling, potentially leading to inhibition of tumor cell proliferation and migration and decreased tumor growth (PMID: 31591377). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05053880 | Phase Ib/II | ACT001 + Pembrolizumab ACT001 | A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme | Unknown status | USA | 0 |